Showing results (2141-2150 of 2,726) with videos related to
Sort By:
Pageof 273
Journal of the International Society of Sports Nutrition|August 19, 2014
L-leucine, beta-hydroxy-beta-methylbutyric acid (HMB) and creatine monohydrate prevent myostatin-induced Akirin-1/Mighty mRNA down-regulation and myotube atrophyChristopher Brooks Mobley, Carlton D Fox, Brian S Ferguson, et al.BMC Pediatrics|November 18, 2015
Current practice of neonatal resuscitation documentation in North America: a multi-center retrospective chart reviewMatthew S Braga, Prakash Kabbur, Pradeep Alur, et al.British Medical Journal|November 10, 1973
Tetracycline and acne vulgaris: a clinical and laboratory investigationW J Cunliffe, R A Forster, N D Greenwood, et al.Transplantation|July 1, 2014
Role of anti-vimentin antibodies in renal transplantationDler Besarani, Lucia Cerundolo, John D Smith, et al.Journal of Medicinal Chemistry|February 6, 2023
Critical Role of Position 10 Residue in the Polymyxin Antimicrobial ActivityNitin A Patil, Wendong Ma, Xukai Jiang, et al.Cancer Treatment Reports|February 1, 1987
Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluationJ D Roberts, J A Stewart, J J McCormack, et al.Australian Veterinary Journal|May 14, 1998
Severity and persistence of footrot in Merino sheep experimentally infected with a protease thermostable strain of Dichelobacter nodosus at five sitesL J Depiazzi, W D Roberts, C D Hawkins, et al.Analytical Biochemistry|February 3, 2007
A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identificationMark P Hodson, Gordon J Dear, Andy D Roberts, et al.Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.British Journal of Rheumatology|February 1, 1986
Multicentre study of piroxicam versus naproxen in juvenile chronic arthritis, with special reference to problem areas in clinical trials of nonsteroidal anti-inflammatory drugs in childhoodP L Williams, B M Ansell, A Bell, et al.Pageof 273